Nkarta, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Nkarta, Inc. (NKTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 459.43 thousand shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2024-11-07
- Nkarta, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 132.58K shares.
- Nkarta, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-06-30 was 45.64K shares.
- Nkarta, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-03-31 was 281.21K shares.
- Nkarta, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 85.83K shares, a 16.95% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2024-09-30 | 132.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 178.22K shares derived: sum of 2 quarters · filed 2024-11-07 | 459.43K shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 45.64K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 326.85K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 281.21K shares 10-Q · filed 2024-05-09 | ||
| 2022-09-30 | 85.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 445.57K shares derived: sum of 2 quarters · filed 2022-11-09 | 565.91K shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 359.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 480.08K shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 120.34K shares 10-Q · filed 2022-05-12 | ||
| 2021-09-30 | 103.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 103.39K shares derived: sum of 2 quarters · filed 2021-11-10 | 119.13K shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 34.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 15.77K shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 15.73K shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |